<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">nss</journal-id>
      <journal-id journal-id-type="pmc">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34113201</article-id>
      <article-id pub-id-type="pmc">8187030</article-id>
      <article-id pub-id-type="publisher-id">311130</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S311130</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Effect of Interaction Between Slow Wave Sleep and Obstructive Sleep Apnea on Insulin Resistance: A Large-Scale Study</article-title>
        <alt-title alt-title-type="running-authors">Huang et al</alt-title>
        <alt-title alt-title-type="running-title">Huang et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Huang</surname>
            <given-names>Weijun</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff0002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff0003">
            <sup>3</sup>
          </xref>
          <xref ref-type="author-notes" rid="ft0001">*</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Liu</surname>
            <given-names>Yuenan</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff0002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff0003">
            <sup>3</sup>
          </xref>
          <xref ref-type="author-notes" rid="ft0001">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Xiaoting</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff0002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff0003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Xinyi</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff0002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff0003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Yupu</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff0002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff0003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zou</surname>
            <given-names>Jianyin</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff0002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff0003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>Huajun</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff0002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff0003">
            <sup>3</sup>
          </xref>
          <xref ref-type="corresp" rid="an0001"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>Huaming</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff0002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff0003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1643-1433</contrib-id>
          <name>
            <surname>Yi</surname>
            <given-names>Hongliang</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff0002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff0003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guan</surname>
            <given-names>Jian</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff0002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff0003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yin</surname>
            <given-names>Shankai</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff0002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff0003">
            <sup>3</sup>
          </xref>
        </contrib>
        <aff id="aff0001"><label>1</label><institution>Department of Otorhinolaryngology Head and Neck Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital</institution>, <addr-line>Shanghai</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0002"><label>2</label><institution>Otolaryngology Institute of Shanghai Jiao Tong University</institution>, <addr-line>Shanghai</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0003"><label>3</label><institution>Shanghai Key Laboratory of Sleep Disordered Breathing</institution>, <addr-line>Shanghai</addr-line>, <country>People’s Republic of China</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="an0001">Correspondence: Huajun Xu; Hongliang Yi Email sunnydayxu2010@163.com; yihongl@126.com</corresp>
        <fn id="ft0001">
          <label>*</label>
          <p><citation_analysis attribute="neither">These authors contributed equally to this work</citation_analysis></p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>04</day>
        <month>6</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>13</volume>
      <fpage>739</fpage>
      <lpage>749</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>3</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>5</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2021 Huang et al.</copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>Huang et al.</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref>
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <sec id="s2001">
          <title>Objective</title>
          <p><citation_analysis attribute="positive">Slow-wave sleep (SWS) and obstructive sleep apnea (OSA) have attracted recent research attention. However, their joint effects on insulin resistance (IR) remain unclear. This study explored whether SWS influences the relationship between OSA and IR.</citation_analysis></p>
        </sec>
        <sec id="s2002">
          <title>Methods</title>
          <p><citation_analysis attribute="positive">We enrolled potential participants in our sleep center from 2007 to 2019. We collected demographic and clinical characteristics and determined IR status. SWS was derived from polysomnography data. Logistic regression analysis was used to reveal the associations between SWS and IR.</citation_analysis></p>
        </sec>
        <sec id="s2003">
          <title>Results</title>
          <p><citation_analysis attribute="positive">In all, 6966 participants (5709 OSA and 1257 primary snoring [PS] subjects) were enrolled. Less SWS increased the risk of IR in OSA patients but not in PS patients. OSA patients with SWS &lt;6.5% were more likely to have IR than were those with SWS &gt;21.3%. OSA was an independent risk factor for IR after adjusting for potential confounding factors. In stratified analyses according to the percentage of SWS, OSA patients with SWS &lt;6.5% had an odds ratio for IR of 2.461 (95% CI, 2.018–3.002) compared to the PS group after adjusting for potential confounders.</citation_analysis></p>
        </sec>
        <sec id="s2004">
          <title>Conclusion</title>
          <p><citation_analysis attribute="negative">Less SWS is associated with higher odds for IR in OSA patients but not in PS patients. OSA is independently associated with IR. In addition, OSA combined with an extreme lack of SWS has a more harmful effect on the status of IR than OSA itself.</citation_analysis></p>
        </sec>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>obstructive sleep apnea</kwd>
        <kwd>slow-wave sleep</kwd>
        <kwd>insulin resistance</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution>Shanghai Municipal Commission of Science and Technology</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
        <funding-statement>The study was granted by grants from Shanghai Municipal Commission of Science and Technology (Grant No.18DZ2260200), Shanghai Science and Technology Innovation Program of Science and Technology Commission (Grant No. 20Y11902100), National Natural Science Foundation of China (Grant No. 81770988, 81970869) and Shanghai Shen-Kang Hospital Management Center Project (Grant No. SHDC2020CR2044B, SHDC2020CR3056B).</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="11"/>
        <ref-count count="47"/>
        <page-count count="11"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Sleep-disordered breathing has attracted research attention, especially in terms of abnormal ventilation during sleep. Obstructive sleep apnea (OSA) is a sleep breathing disorder with a prevalence of 3.5–4.6% in adults and 2–8% in children.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="negative"> In OSA subjects, repeated upper airway obstruction during sleep can lead to decreased blood oxygen saturation and sleep disorders. OSA increases the risk of cardiovascular, cerebrovascular, and metabolic diseases, leading to loss of work and death among middle-aged and elderly people.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> In addition, sleep fragmentation can cause daytime sleepiness, which then increases the incidence of related traffic accidents. Therefore, OSA has become an important public health problem.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">As we all know, the sleep period consists of rapid eye movement (REM) and non-rapid eye movement (NREM), which alternate during sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither"> Slow-wave sleep (SWS or N3) stages is one of the NREM sleep apart from N1 and N2 stage.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither"> Circadian rhythms and homeostatic processes regulate sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0009" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither"> The circadian rhythm is driven by the internal biological clock and is synchronized with the light/dark cycle, which can regulate sleep tendency throughout the entire day (24 h). Homeostatic processes express the sleep pressure that accumulates during wakefulness and determine the duration of sleep, and more specifically the percentage of SWS. SWS, or deep sleep, is thus a homeostatic process thought to reflect the restorative role of sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis></p>
      <p><citation_analysis attribute="negative">A growing number of people experience poor sleep quality due to sleep fragmentation and other factors, and sleep deprivation is becoming a major problem. We should be paying more attention to OSA and SWS suppression, which are common globally, and are thought to be independent risk factors for metabolic,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="neither"> cognitive,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither"> and cardiovascular problems.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">The significance of SWS is not restricted to neurophysiological restoration but encompasses a broad range of functions. Increasing evidence supports a crucial role for SWS in modulating a multitude of physiological processes, including memory consolidation,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="neither"> energy conservation,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither"> clearance of metabolites,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither"> and immunity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> Other neuroendocrine changes that occur during SWS include increased release of growth hormone, higher insulin sensitivity, and decreased corticotropic and sympathetic nervous system activity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither"> During SWS sleep, the upper airway appears to be less susceptible in OSA patients compared to their REM and NREM sleep stages. The apnea-hypopnea index (AHI) and lowest oxygen saturation clearly improve in most patients once they have achieved the SWS stage.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis></p>
      <p><citation_analysis attribute="negative">Insulin resistance (IR) leads to various adverse clinical outcomes and increases the risk for the diseases mentioned above because of the decreased cellular response to insulin.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="neither"> IR is associated with sleep apnea</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither"> and SWS deprivation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither"> An experimental SWS deprivation model predicted a decrease in insulin sensitivity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="negative"> In another study, SWS was not related to fasting blood glucose, insulin, or C-peptide levels when adolescents had mixed meals, nor did it impair insulin sensitivity or β-cell reactivity but young healthy-weight adults showed a decline of 25% from baseline insulin sensitivity after SWS suppression for 3 days.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Other studies have had different outcomes. In one, less REM sleep led to higher cortisol concentrations and a higher homeostatic model assessment of insulin resistance (HOMA-IR) index, with no correlation between SWS and the index.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither"> In another, variation in SWS was related to variation in glucose metabolism but not insulin sensitivity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Despite such studies, the severity and medical implications of sleep disorders are seldom considered. Many sleep-related breathing disorders can lead to significant suppression of SWS. Little is known of the effects of less SWS in OSA, particularly with regard to IR. Whether OSA and decreased SWS are independently correlated with IR has not been determined. Moreover, these associations in Han Chinese populations have not yet been explored.</citation_analysis></p>
      <p><citation_analysis attribute="neither">We performed a large-scale, hospital-based study to explore whether an objectively measured decrease in SWS% and OSA are independently associated with IR, and whether SWS influences the relationship between OSA and IR.</citation_analysis></p>
    </sec>
    <sec id="s0002">
      <title>Methods</title>
      <p><citation_analysis attribute="positive">Study subjects were enrolled from 2007 to 2019 at our sleep center. This study was performed in accordance with the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of Shanghai Jiao Tong University Affiliated Sixth People’s Hospital (Approval No: 2019-KY-050[K]) and was registered at the Chinese Clinical Trial Registry (No. ChiCTR1900025714). We obtained informed consent from all subjects.</citation_analysis></p>
      <sec id="s0002-s2001">
        <title>Subject Recruitment</title>
        <p><citation_analysis attribute="neither">Subjects were enrolled according to the following inclusion and exclusion criteria. All participants were adults (aged ≥ 18 years) and underwent standard polysomnography (PSG). OSA patients had not previously been treated. Subjects with chronic diseases such as pulmonary, hepatic, and cardiac disease, or other comorbid sleep disorders (insomnia, upper airway resistance syndrome, narcolepsy and restless legs syndrome) were excluded. The participants did not take anxiolytics, antidepressants, hypnotics, antipsychotics, or anti-diabetes drugs. We learned about their general health status including habits such as smoking, alcohol consumption, and medication use through a comprehensive questionnaire. Participants completed the Epworth Sleepiness Scale (ESS).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="neither"> Those who scored an ESS value &gt; 10 were considered to have excessive daytime sleepiness (EDS).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Clinical and Biochemical Measurements</title>
        <p><citation_analysis attribute="neither">We used the mean values of two consecutive measurements to assess the physical condition of subjects including height (m), weight (kg), circumferences of neck, waist, and hip (cm), and blood pressure (mmHg), before PSG.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="neither"> Blood pressure was measured by a standard mercury sphygmomanometer after resting for 15 min. Body mass index (BMI) was the weight divided by the height squared (kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="positive">). At 07:00 the next morning, fasting blood samples were taken from each participant. The glycolipid metabolism index was measured in our laboratory. The HOMA-IR index was calculated as fasting insulin (μU/mL) multiplied by fasting glucose (mmol/L) and the result divided by 22.5.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="neither"> Subjects with HOMA-IR ≥ 2.5 were classified into the IR group.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="positive"> Subjects diagnosed by their physician and using antihypertensive medications were considered to have hypertension. The diagnoses of diabetes and hyperlipidemia relied on their past history and the lipid index according to the 2016 ESC/EAS guidelines for the management of dyslipidemias.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis></p>
      </sec>
      <sec id="s0002-s2003">
        <title>Polysomnography</title>
        <p><citation_analysis attribute="positive">All enrolled participants underwent full-night standard PSG at our sleep center using Alice 4, 5 or 6 devices (Respironics Inc, Pittsburgh, PA, USA). A skilled technician manually checked the data and PSG output reports according to the AASM 2007 guidelines.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0033" ref-type="bibr">33</xref></citation_analysis><citation_analysis attribute="positive"> SWS was expressed as a percentage of TST and categorized into quartiles (for patients with OSA: &gt; 21.3%, 13.1–21.3%, 6.5–13% and &lt; 6.5%; for primary snorers: &gt; 24.7%, 17.1–24.7%, 10.6–17%, &lt; 10.6%). Patients with an AHI ≥ 5 events/h were included in the OSA group, while subjects with an AHI &lt; 5 events/h were considered primary snoring (PS) subjects. Then OSA was classified into mild (AHI ≥ 5, &lt; 15/h), moderate (AHI ≥ 15, &lt; 30/h), and severe OSA (AHI ≥ 30/h).</citation_analysis></p>
      </sec>
      <sec id="s0002-s2004">
        <title>Statistical Analyses</title>
        <p><citation_analysis attribute="positive">The sample size was determined based on power analysis. According to our data, 27.53% of primary snorers have IR, compared to 57.3% of those with OSA. With a power of 90% and α of 0.05, 228 participants were required. Assuming an attrition rate of 15%, a minimum of 263 participants were required. Continuous variables are shown as means ± SD. Skewed data are presented as the median (IQR). Categorical data are presented as percentages. We used ANOVA, </citation_analysis><citation_analysis attribute="positive"><italic>t</italic></citation_analysis><citation_analysis attribute="neither"> test, the Kruskal–Wallis tests, and the χ</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="positive"> test to further analyze the data. OSA and non-OSA (primary snorers with an AHI &lt; 5) groups were compared. For SWS, quartile reference groups were established and we used the highest SWS quartile as reference group. We used the polynomial linear trend test to calculate p-values for linear trends across groups. Logistic regression was used to analyze the associations between SWS and IR. Sex, age, BMI, alcohol consumption, smoking, hypertension, hyperlipidemia, TST, sleep efficiency (SE), ESS, and AHI (or SWS%) were considered covariates. A p-value &lt; 0.05 indicated statistical significance. All statistical analyses were performed using SPSS software version 22.0 (IBM SPSS Statistics, IBM Corp., Armonk, NY, USA).</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Results</title>
      <p><citation_analysis attribute="positive">The sample included 6966 subjects, of which 5709 were OSA patients (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">). An overwhelming majority of OSA patients were male, heavier, and older, with poorer metabolic profiles compared to simple snorers. </citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><underline><ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/get_supplementary_file.php?f= 311130.docx">Table S1</ext-link></underline></citation_analysis><citation_analysis attribute="positive"> summarized the demographics and clinical characteristics of OSA and PS subjects stratified according to the percentage of SWS, respectively. In the OSA group, patients with a lower percentage of SWS were older, and had a higher BMI, higher prevalence of IR, higher AHI, and lower nocturnal oxygen saturation. On the contrary, no instructive significant difference in PS subjects was found (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/get_supplementary_file.php?f= 311130.docx">Table S1</ext-link></underline></citation_analysis><citation_analysis attribute="neither">). In the whole cohort, OSA was independently correlated with IR after adjustment for potential confounding factors (OR, 1.876 [95% CI, 1. 592–2.211]) (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="positive">). As shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="positive">, subjects with SWS &lt; 6.9% were 37.1% (odds ratio [OR], 1.371 [95% CI, 1.175–1.600]) more likely to have IR compared to those with SWS &gt; 22.1% after adjusting for age, BMI, sex, alcohol consumption, smoking, hypertension, diabetes mellitus, and hyperlipidemia. However, significance disappeared after further adjusting for TST, SE, ESS, and AHI. Hence, SWS was not independently associated with IR in the whole cohort. The joint effect of OSA and SWS on IR were also presented in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">. Significantly increased odds of IR were found among OSA patients with a lower percentage of SWS. After adjusting for age, BMI, sex, alcohol consumption, smoking, hypertension, diabetes mellitus, hyperlipidemia, TST, SE and ESS, OSA patients with SWS &lt; 6.5% had an odds ratio for IR of 2.461 (95% CI, 2.018–3.002) compared to the PS group (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1</label><caption><p><citation_analysis attribute="neither">Clinical and Sleep Characteristics of Subjects Stratified by OSA Severity Categories</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Characteristics</th><th colspan="3" rowspan="1">Whole Cohort</th><th colspan="4" rowspan="1">OSA</th></tr><tr><th rowspan="1" colspan="1">PS<break/>(n = 1257)</th><th rowspan="1" colspan="1">Total OSA<break/>(n = 5709)</th><th rowspan="1" colspan="1">p-value 1</th><th rowspan="1" colspan="1">Mild OSA<break/>(n = 1115)</th><th rowspan="1" colspan="1">Moderate OSA<break/>(n = 1133)</th><th rowspan="1" colspan="1">Severe OSA<break/>(n = 3461)</th><th rowspan="1" colspan="1">p-value 2</th></tr></thead><tbody><tr><td colspan="8" rowspan="1">Demographic and clinical characteristics</td></tr><tr><td rowspan="1" colspan="1">Men, n (%)</td><td rowspan="1" colspan="1">788 (62.69)</td><td rowspan="1" colspan="1">4777 (83.67)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">829 (74.3)</td><td rowspan="1" colspan="1">893 (78.8)</td><td rowspan="1" colspan="1">3055 (88.3)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Age, y</td><td rowspan="1" colspan="1">39.55±12.02</td><td rowspan="1" colspan="1">44.57±12.21</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">43.15±12.67</td><td rowspan="1" colspan="1">45.74±12.80</td><td rowspan="1" colspan="1">44.64±11.82</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Neck circumference (cm)</td><td rowspan="1" colspan="1">36.60±3.96</td><td rowspan="1" colspan="1">39.87±3.53</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">38.19±3.31</td><td rowspan="1" colspan="1">38.97±3.31</td><td rowspan="1" colspan="1">40.70±3.40</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Waist circumference (cm)</td><td rowspan="1" colspan="1">86.97±10.68</td><td rowspan="1" colspan="1">97.44±10.55</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">92.25±9.73</td><td rowspan="1" colspan="1">95.02±9.79</td><td rowspan="1" colspan="1">99.89±10.27</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Hip circumference (cm)</td><td rowspan="1" colspan="1">96.82±7.31</td><td rowspan="1" colspan="1">102.22±7.89</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">99.53±7.46</td><td rowspan="1" colspan="1">100.80±7.38</td><td rowspan="1" colspan="1">103.55±7.89</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Waist hip ratio</td><td rowspan="1" colspan="1">0.90±0.07</td><td rowspan="1" colspan="1">0.95±0.06</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">0.93±0.06</td><td rowspan="1" colspan="1">0.94±0.06</td><td rowspan="1" colspan="1">0.96±0.06</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Body mass index, kg/m<xref rid="cit0002" ref-type="bibr">2</xref></td><td rowspan="1" colspan="1">24.25±3.72</td><td rowspan="1" colspan="1">27.31±3.87</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">25.72±3.49</td><td rowspan="1" colspan="1">26.48±3.56</td><td rowspan="1" colspan="1">28.07±3.87</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Hypertension, n (%)</td><td rowspan="1" colspan="1">132 (10.50)</td><td rowspan="1" colspan="1">1508 (26.41)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">197 (17.7)</td><td rowspan="1" colspan="1">276 (24.4)</td><td rowspan="1" colspan="1">1035 (29.9)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">SBP (mmHg)</td><td rowspan="1" colspan="1">120.49±14.80</td><td rowspan="1" colspan="1">127.81±16.06</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">124.47±14.95</td><td rowspan="1" colspan="1">126.22±16.36</td><td rowspan="1" colspan="1">129.37±16.09</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">DBP (mmHg)</td><td rowspan="1" colspan="1">77.40±10.21</td><td rowspan="1" colspan="1">82.01±11.79</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">79.01±11.21</td><td rowspan="1" colspan="1">80.03±11.24</td><td rowspan="1" colspan="1">83.58±11.86</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Diabetes mellitus, n (%)</td><td rowspan="1" colspan="1">65 (5.17)</td><td rowspan="1" colspan="1">450 (7.88)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">83 (7.4)</td><td rowspan="1" colspan="1">106 (9.4)</td><td rowspan="1" colspan="1">261 (7.5)</td><td rowspan="1" colspan="1">0.12</td></tr><tr><td rowspan="1" colspan="1">Hyperlipidemia, n (%)</td><td rowspan="1" colspan="1">164 (13.05)</td><td rowspan="1" colspan="1">1892 (33.14)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">306 (27.4)</td><td rowspan="1" colspan="1">345 (30.5)</td><td rowspan="1" colspan="1">1241 (35.9)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Tobacco use, n (%)</td><td rowspan="1" colspan="1">235 (18.70)</td><td rowspan="1" colspan="1">1137 (19.92)</td><td rowspan="1" colspan="1">0.172</td><td rowspan="1" colspan="1">218 (19.6)</td><td rowspan="1" colspan="1">219 (19.3)</td><td rowspan="1" colspan="1">700 (20.2)</td><td rowspan="1" colspan="1">0.761</td></tr><tr><td rowspan="1" colspan="1">Alcohol consumption, n (%)</td><td rowspan="1" colspan="1">599 (47.65)</td><td rowspan="1" colspan="1">2972 (52.06)</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1">567 (50.9)</td><td rowspan="1" colspan="1">588 (51.9)</td><td rowspan="1" colspan="1">1817 (52.5)</td><td rowspan="1" colspan="1">0.628</td></tr><tr><td rowspan="1" colspan="1">Fasting glucose (mmol/L)</td><td rowspan="1" colspan="1">5.14±1.11</td><td rowspan="1" colspan="1">5.61±1.34</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">5.39±1.29</td><td rowspan="1" colspan="1">5.52±1.27</td><td rowspan="1" colspan="1">5.71±1.37</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Fasting insulin (µU/mL)</td><td rowspan="1" colspan="1">7.69(5.91)</td><td rowspan="1" colspan="1">11.72(9.47)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">9.25(7.56)</td><td rowspan="1" colspan="1">10.46(7.72)</td><td rowspan="1" colspan="1">12.87(10.05)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">IR</td><td rowspan="1" colspan="1">346 (27.53)</td><td rowspan="1" colspan="1">3271 (57.30)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">465 (41.7)</td><td rowspan="1" colspan="1">569 (50.2)</td><td rowspan="1" colspan="1">2237 (64.6)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">HOMA-IR</td><td rowspan="1" colspan="1">1.73(1.47)</td><td rowspan="1" colspan="1">2.82(2.58)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.10(1.92)</td><td rowspan="1" colspan="1">2.47(1.96)</td><td rowspan="1" colspan="1">3.14(2.80)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Cholesterol (mmol/L)</td><td rowspan="1" colspan="1">4.36(1.15)</td><td rowspan="1" colspan="1">4.77(1.21)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">4.59(1.20)</td><td rowspan="1" colspan="1">4.72(1.18)</td><td rowspan="1" colspan="1">4.83(1.21)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Triglyceride (mmol/L)</td><td rowspan="1" colspan="1">1.19(0.96)</td><td rowspan="1" colspan="1">1.67(1.25)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.41(1.00)</td><td rowspan="1" colspan="1">1.63(1.19)</td><td rowspan="1" colspan="1">1.78(1.31)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">High density<break/>Lipoprotein (mmol/L)</td><td rowspan="1" colspan="1">1.10(0.34)</td><td rowspan="1" colspan="1">1.02(0.28)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.06(0.33)</td><td rowspan="1" colspan="1">1.04(0.30)</td><td rowspan="1" colspan="1">1.00(0.26)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Low density<break/>Lipoprotein (mmol/L)</td><td rowspan="1" colspan="1">2.62(1.00)</td><td rowspan="1" colspan="1">2.99(1.04)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.91(1.03)</td><td rowspan="1" colspan="1">2.96(1.00)</td><td rowspan="1" colspan="1">3.03(1.05)</td><td rowspan="1" colspan="1">0.013</td></tr><tr><td rowspan="1" colspan="1">ApolipoproteinA-1 (g/L)</td><td rowspan="1" colspan="1">1.07(0.26)</td><td rowspan="1" colspan="1">1.05(0.24)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.06(0.26)</td><td rowspan="1" colspan="1">1.05(0.24)</td><td rowspan="1" colspan="1">1.05(0.23)</td><td rowspan="1" colspan="1">0.007</td></tr><tr><td rowspan="1" colspan="1">Apolipoprotein-B (g/L)</td><td rowspan="1" colspan="1">0.74(0.25)</td><td rowspan="1" colspan="1">0.85(0.25)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">0.82(0.24)</td><td rowspan="1" colspan="1">0.84(0.24)</td><td rowspan="1" colspan="1">0.88(0.24)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Apolipoprotein-E (mg/dL)</td><td rowspan="1" colspan="1">3.79(1.55)</td><td rowspan="1" colspan="1">4.31(1.89)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">4.01(1.60)</td><td rowspan="1" colspan="1">4.28(1.77)</td><td rowspan="1" colspan="1">4.43(2.03)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Lipoprotein-α (mg/dL)</td><td rowspan="1" colspan="1">7.80(13.73)</td><td rowspan="1" colspan="1">7.30(11.50)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">8.10(13.10)</td><td rowspan="1" colspan="1">7.40(11.20)</td><td rowspan="1" colspan="1">7.10(11.00)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">ESS</td><td rowspan="1" colspan="1">5.00(9.00)_</td><td rowspan="1" colspan="1">8.00(9.00)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">7.00(8.00)</td><td rowspan="1" colspan="1">6.00(9.00)</td><td rowspan="1" colspan="1">9.00(9.00)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">ESS &gt; 10, n (%)</td><td rowspan="1" colspan="1">193 (15.35)</td><td rowspan="1" colspan="1">2066 (36.19)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">248 (22.2)</td><td rowspan="1" colspan="1">288 (25.4)</td><td rowspan="1" colspan="1">1530 (44.2)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td colspan="8" rowspan="1">Polysomnography</td></tr><tr><td rowspan="1" colspan="1">Total sleep time, min</td><td rowspan="1" colspan="1">379.89±81.89</td><td rowspan="1" colspan="1">397.34±77.46</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">384.94±80.30</td><td rowspan="1" colspan="1">388.07±78.24</td><td rowspan="1" colspan="1">404.37±75.45</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Sleep efficiency, %</td><td rowspan="1" colspan="1">89.44±13.51</td><td rowspan="1" colspan="1">90.57±13.02</td><td rowspan="1" colspan="1">0.007</td><td rowspan="1" colspan="1">89.49±12.76</td><td rowspan="1" colspan="1">90.18±12.32</td><td rowspan="1" colspan="1">91.05±13.29</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1">N1, % TST</td><td rowspan="1" colspan="1">18.84±12.82</td><td rowspan="1" colspan="1">21.32±14.30</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">20.31±13.54</td><td rowspan="1" colspan="1">20.58±13.76</td><td rowspan="1" colspan="1">21.89±14.68</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1">N2, % TST</td><td rowspan="1" colspan="1">49.62±14.99</td><td rowspan="1" colspan="1">51.16±16.15</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1">49.03±15.81</td><td rowspan="1" colspan="1">49.99±16.11</td><td rowspan="1" colspan="1">52.23±16.18</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">SWS, % TST</td><td rowspan="1" colspan="1">18.74±12.19</td><td rowspan="1" colspan="1">15.78±13.01</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">18.46±12.48</td><td rowspan="1" colspan="1">17.51±12.18</td><td rowspan="1" colspan="1">14.34±13.23</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">REM, % TST</td><td rowspan="1" colspan="1">12.59±7.03</td><td rowspan="1" colspan="1">11.26±6.63</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">11.83±7.21</td><td rowspan="1" colspan="1">11.51±6.85</td><td rowspan="1" colspan="1">11.00±6.35</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">AHI, events/h</td><td rowspan="1" colspan="1">1.80(2.60)</td><td rowspan="1" colspan="1">39.50(43.20)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">9.40(5.10)</td><td rowspan="1" colspan="1">21.70(7.20)</td><td rowspan="1" colspan="1">57.4(25.70)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Lowest SaO2, %</td><td rowspan="1" colspan="1">93.00(5.00)</td><td rowspan="1" colspan="1">78.00(17.00)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">88.00(7.00)</td><td rowspan="1" colspan="1">83.00(9.00)</td><td rowspan="1" colspan="1">71.50(16.00)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">ODI, events/h</td><td rowspan="1" colspan="1">1.90(2.90)</td><td rowspan="1" colspan="1">39.00(43.85)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">9.40(6.00)</td><td rowspan="1" colspan="1">21.90(9.55)</td><td rowspan="1" colspan="1">57.10(28.50)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Mean SaO2</td><td rowspan="1" colspan="1">97.00(1.00)</td><td rowspan="1" colspan="1">94.00(4.00)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">96.00(2.00)</td><td rowspan="1" colspan="1">95.00(2.00)</td><td rowspan="1" colspan="1">93.00(4.00)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Micro arousal index, events/h</td><td rowspan="1" colspan="1">13.10(12.05)</td><td rowspan="1" colspan="1">26.10(29.70)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">17.10(14.60)</td><td rowspan="1" colspan="1">20.60(17.95)</td><td rowspan="1" colspan="1">34.60(34.10)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="positive">: Continuous variables were shown as the mean ± SD. Skewed data were presented as median (IQR). Categorical data were presented as the number (percentage). ANOVA, the Kruskal–Wallis tests, and the χ2 test were used to further analyze the data. P-value 1: significant difference between PS and total OSA groups. P-value 2: significant difference among all groups (mild OSA, moderate OSA and severe OSA).</citation_analysis></p></fn><fn id="tfn0002"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: OSA, obstructive sleep apnea; PS, primary snorers; SBP, systolic blood pressure; DBP, diastolic blood pressure; IR, insulin resistance; HOMA-IR, homeostasis model assessment of insulin resistance; ESS, Epworth Sleepiness Scale; SWS, slow wave sleep; REM, rapid eye movement; AHI, apnea-hypopnea index; SaO2, oxygen saturation, ODI, oxygen desaturation index.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2</label><caption><p><citation_analysis attribute="neither">Clinical and Sleep Characteristics of OSA Patients (n=5709) Stratified by SWS Categories</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Characteristics</th><th rowspan="1" colspan="1">&gt;21.3%<break/>(n = 1427)</th><th rowspan="1" colspan="1">13.1–21.3%<break/>(n = 1434)</th><th rowspan="1" colspan="1">6.5–13%<break/>(n = 1412)</th><th rowspan="1" colspan="1">&lt;6.5%<break/>(n = 1436)</th><th rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td colspan="6" rowspan="1">Demographic and clinical characteristics</td></tr><tr><td rowspan="1" colspan="1">Men, n (%)</td><td rowspan="1" colspan="1">1123 (78.7)</td><td rowspan="1" colspan="1">1174 (81.9)</td><td rowspan="1" colspan="1">1206 (85.4)</td><td rowspan="1" colspan="1">1274 (88.7)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Age, y</td><td rowspan="1" colspan="1">43.56±12.32</td><td rowspan="1" colspan="1">43.85±12.36</td><td rowspan="1" colspan="1">44.38±11.97</td><td rowspan="1" colspan="1">46.47±11.99</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Neck circumference (cm)</td><td rowspan="1" colspan="1">39.43±3.54</td><td rowspan="1" colspan="1">39.49±3.48</td><td rowspan="1" colspan="1">40.15±3.45</td><td rowspan="1" colspan="1">40.45±3.53</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Waist circumference (cm)</td><td rowspan="1" colspan="1">97.04±10.70</td><td rowspan="1" colspan="1">96.30±10.60</td><td rowspan="1" colspan="1">97.66±10.35</td><td rowspan="1" colspan="1">98.84±10.41</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Hip circumference (cm)</td><td rowspan="1" colspan="1">102.01±8.11</td><td rowspan="1" colspan="1">101.57±7.87</td><td rowspan="1" colspan="1">102.67±7.65</td><td rowspan="1" colspan="1">102.68±7.89</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Waist hip ratio</td><td rowspan="1" colspan="1">0.95±0.06</td><td rowspan="1" colspan="1">0.95±0.06</td><td rowspan="1" colspan="1">0.95±0.06</td><td rowspan="1" colspan="1">0.96±0.06</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Body mass index, kg/m<xref rid="cit0002" ref-type="bibr">2</xref></td><td rowspan="1" colspan="1">27.24±4.01</td><td rowspan="1" colspan="1">27.00±3.78</td><td rowspan="1" colspan="1">27.36±3.73</td><td rowspan="1" colspan="1">27.66±3.91</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Hypertension, n (%)</td><td rowspan="1" colspan="1">374 (26.2)</td><td rowspan="1" colspan="1">334 (23.3)</td><td rowspan="1" colspan="1">368 (26.1)</td><td rowspan="1" colspan="1">432 (30.1)</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1">SBP (mmHg)</td><td rowspan="1" colspan="1">127.86±16.56</td><td rowspan="1" colspan="1">126.91±15.80</td><td rowspan="1" colspan="1">128.10±15.82</td><td rowspan="1" colspan="1">128.43±16.02</td><td rowspan="1" colspan="1">0.088</td></tr><tr><td rowspan="1" colspan="1">DBP (mmHg)</td><td rowspan="1" colspan="1">81.78±12.41</td><td rowspan="1" colspan="1">81.23±11.38</td><td rowspan="1" colspan="1">82.19±11.66</td><td rowspan="1" colspan="1">92.93±11.61</td><td rowspan="1" colspan="1">0.003</td></tr><tr><td rowspan="1" colspan="1">Diabetes mellitus, n (%)</td><td rowspan="1" colspan="1">116 (8.1)</td><td rowspan="1" colspan="1">105 (7.3)</td><td rowspan="1" colspan="1">111 (7.9)</td><td rowspan="1" colspan="1">118 (8.2)</td><td rowspan="1" colspan="1">0.810</td></tr><tr><td rowspan="1" colspan="1">Hyperlipidemia, n (%)</td><td rowspan="1" colspan="1">469 (23.9)</td><td rowspan="1" colspan="1">475 (33.1)</td><td rowspan="1" colspan="1">445 (31.5)</td><td rowspan="1" colspan="1">503 (35.0)</td><td rowspan="1" colspan="1">0.257</td></tr><tr><td rowspan="1" colspan="1">Tobacco use, n (%)</td><td rowspan="1" colspan="1">301 (21.1)</td><td rowspan="1" colspan="1">254 (17.7)</td><td rowspan="1" colspan="1">288 (20.4)</td><td rowspan="1" colspan="1">294 (20.5)</td><td rowspan="1" colspan="1">0.107</td></tr><tr><td rowspan="1" colspan="1">Alcohol consumption, n (%)</td><td rowspan="1" colspan="1">755 (52.9)</td><td rowspan="1" colspan="1">805 (56.1)</td><td rowspan="1" colspan="1">744 (52.7)</td><td rowspan="1" colspan="1">668 (46.5)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Fasting glucose (mmol/L)</td><td rowspan="1" colspan="1">5.56±1.25</td><td rowspan="1" colspan="1">5.61±1.43</td><td rowspan="1" colspan="1">5.58±1.30</td><td rowspan="1" colspan="1">5.70±1.38</td><td rowspan="1" colspan="1">0.032</td></tr><tr><td rowspan="1" colspan="1">Fasting insulin (µU/mL)</td><td rowspan="1" colspan="1">11.53(9.20)</td><td rowspan="1" colspan="1">11.06(8.55)</td><td rowspan="1" colspan="1">11.49(9.24)</td><td rowspan="1" colspan="1">12.77(10.08)</td><td rowspan="1" colspan="1">0.638</td></tr><tr><td rowspan="1" colspan="1">IR</td><td rowspan="1" colspan="1">795 (55.7)</td><td rowspan="1" colspan="1">771 (53.8)</td><td rowspan="1" colspan="1">783 (55.5)</td><td rowspan="1" colspan="1">922 (64.2)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">HOMA-IR</td><td rowspan="1" colspan="1">2.72(2.48)</td><td rowspan="1" colspan="1">2.65(2.29)</td><td rowspan="1" colspan="1">2.72(2.48)</td><td rowspan="1" colspan="1">3.12(2.79)</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1">Cholesterol (mmol/L)</td><td rowspan="1" colspan="1">4.76(1.25)</td><td rowspan="1" colspan="1">4.77(1.19)</td><td rowspan="1" colspan="1">4.75(1.17)</td><td rowspan="1" colspan="1">4.79(1.24)</td><td rowspan="1" colspan="1">0.218</td></tr><tr><td rowspan="1" colspan="1">Triglyceride (mmol/L)</td><td rowspan="1" colspan="1">1.62(1.22)</td><td rowspan="1" colspan="1">1.66(1.25)</td><td rowspan="1" colspan="1">1.69(1.19)</td><td rowspan="1" colspan="1">1.75(1.33)</td><td rowspan="1" colspan="1">0.093</td></tr><tr><td rowspan="1" colspan="1">High density lipoprotein (mmol/L)</td><td rowspan="1" colspan="1">1.01(0.27)</td><td rowspan="1" colspan="1">1.03(0.29)</td><td rowspan="1" colspan="1">1.02(0.27)</td><td rowspan="1" colspan="1">1.01(0.28)</td><td rowspan="1" colspan="1">0.072</td></tr><tr><td rowspan="1" colspan="1">Low density lipoprotein (mmol/L)</td><td rowspan="1" colspan="1">2.94(1.02)</td><td rowspan="1" colspan="1">2.98(1.04)</td><td rowspan="1" colspan="1">3.01(1.01)</td><td rowspan="1" colspan="1">3.04(1.11)</td><td rowspan="1" colspan="1">0.003</td></tr><tr><td rowspan="1" colspan="1">ApolipoproteinA-1 (g/L)</td><td rowspan="1" colspan="1">1.05(0.23)</td><td rowspan="1" colspan="1">1.04(0.23)</td><td rowspan="1" colspan="1">1.04(0.23)</td><td rowspan="1" colspan="1">1.07(0.24)</td><td rowspan="1" colspan="1">0.003</td></tr><tr><td rowspan="1" colspan="1">Apolipoprotein-B (g/L)</td><td rowspan="1" colspan="1">0.85(0.24)</td><td rowspan="1" colspan="1">0.85(0.26)</td><td rowspan="1" colspan="1">0.85(0.24)</td><td rowspan="1" colspan="1">0.88(0.26)</td><td rowspan="1" colspan="1">0.025</td></tr><tr><td rowspan="1" colspan="1">Apolipoprotein-E (mg/dL)</td><td rowspan="1" colspan="1">4.31(1.95)</td><td rowspan="1" colspan="1">4.23(1.84)</td><td rowspan="1" colspan="1">4.26(1.76)</td><td rowspan="1" colspan="1">4.44(1.99)</td><td rowspan="1" colspan="1">0.023</td></tr><tr><td rowspan="1" colspan="1">Lipoprotein-α (mg/dL)</td><td rowspan="1" colspan="1">7.60(12.60)</td><td rowspan="1" colspan="1">7.80(11.95)</td><td rowspan="1" colspan="1">6.90(10.50)</td><td rowspan="1" colspan="1">7.20(10.80)</td><td rowspan="1" colspan="1">0.104</td></tr><tr><td rowspan="1" colspan="1">ESS</td><td rowspan="1" colspan="1">8.00(9.00)</td><td rowspan="1" colspan="1">8.00(8.00)</td><td rowspan="1" colspan="1">8.00(9.00)</td><td rowspan="1" colspan="1">9.00(10.00)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">ESS &gt; 10, n (%)</td><td rowspan="1" colspan="1">438 (30.7)</td><td rowspan="1" colspan="1">505 (35.2)</td><td rowspan="1" colspan="1">519 (36.8)</td><td rowspan="1" colspan="1">604 (42.1)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td colspan="6" rowspan="1">Polysomnography</td></tr><tr><td rowspan="1" colspan="1">Total sleep time, min</td><td rowspan="1" colspan="1">403.91±77.74</td><td rowspan="1" colspan="1">401.68±71.05</td><td rowspan="1" colspan="1">399.09±73.71</td><td rowspan="1" colspan="1">384.72±85.18</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Sleep efficiency, %</td><td rowspan="1" colspan="1">92.36±11.83</td><td rowspan="1" colspan="1">91.54±10.45</td><td rowspan="1" colspan="1">91.19±10.70</td><td rowspan="1" colspan="1">87.21±17.24</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">N1, % TST</td><td rowspan="1" colspan="1">17.87±12.77</td><td rowspan="1" colspan="1">17.94±10.96</td><td rowspan="1" colspan="1">20.64±12.63</td><td rowspan="1" colspan="1">28.80±17.17</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">N2, % TST</td><td rowspan="1" colspan="1">38.09±16.22</td><td rowspan="1" colspan="1">52.84±10.96</td><td rowspan="1" colspan="1">57.16±12.44</td><td rowspan="1" colspan="1">56.57±16.31</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">SWS, % TST</td><td rowspan="1" colspan="1">33.96±10.88</td><td rowspan="1" colspan="1">16.87±2.35</td><td rowspan="1" colspan="1">9.77±1.91</td><td rowspan="1" colspan="1">2.52±2.21</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">REM, % TST</td><td rowspan="1" colspan="1">9.95±6.82</td><td rowspan="1" colspan="1">11.86±6.34</td><td rowspan="1" colspan="1">11.75±6.45</td><td rowspan="1" colspan="1">11.48±6.75</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">AHI, events/h</td><td rowspan="1" colspan="1">33.90(39.40)</td><td rowspan="1" colspan="1">31.60(37.70)</td><td rowspan="1" colspan="1">42.30(41.35)</td><td rowspan="1" colspan="1">57.20(36.30)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Lowest SpO2, %</td><td rowspan="1" colspan="1">78.00(17.00)</td><td rowspan="1" colspan="1">80.00(15.00)</td><td rowspan="1" colspan="1">78.00(17.00)</td><td rowspan="1" colspan="1">75.00(18.00)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">ODI</td><td rowspan="1" colspan="1">31.70(39.60)</td><td rowspan="1" colspan="1">32.70(38.60)</td><td rowspan="1" colspan="1">41.40(41.90)</td><td rowspan="1" colspan="1">56.30(37.60)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Mean SaO2</td><td rowspan="1" colspan="1">94.00(4.00)</td><td rowspan="1" colspan="1">95.00(3.00)</td><td rowspan="1" colspan="1">94.00(3.90)</td><td rowspan="1" colspan="1">93.00(4.00)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Mild OSA, n (%)</td><td rowspan="1" colspan="1">350 (24.5)</td><td rowspan="1" colspan="1">352 (24.5)</td><td rowspan="1" colspan="1">254 (18)</td><td rowspan="1" colspan="1">159 (11.1)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Moderate OSA, n (%)</td><td rowspan="1" colspan="1">322 (22.6)</td><td rowspan="1" colspan="1">345 (24.1)</td><td rowspan="1" colspan="1">291 (20.6)</td><td rowspan="1" colspan="1">175 (12.2)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Severe OSA, n (%)</td><td rowspan="1" colspan="1">755 (52.9)</td><td rowspan="1" colspan="1">737 (51.4)</td><td rowspan="1" colspan="1">867 (61.4)</td><td rowspan="1" colspan="1">1102 (76.7)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Micro arousal index, events/h</td><td rowspan="1" colspan="1">19.50(22.80)</td><td rowspan="1" colspan="1">22.80(22.70)</td><td rowspan="1" colspan="1">28.20(28.25)</td><td rowspan="1" colspan="1">39.00(36.80)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="positive">: Continuous variables were shown as the mean ± SD. Skewed data were presented as median (IQR). Categorical data were presented as the number (percentage). ANOVA, the Kruskal–Wallis tests, and the χ2 test were used to further analyze the data. P-value: significant difference among all four groups.</citation_analysis></p><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: OSA, obstructive sleep apnea; SWS, slow wave sleep; SBP, systolic blood pressure; DBP, diastolic blood pressure; IR, insulin resistance; HOMA-IR, homeostasis model assessment of insulin resistance; ESS, Epworth Sleepiness Scale; REM, rapid eye movement; AHI, apnea-hypopnea index; SpO2, oxygen saturation; ODI, oxygen desaturation index.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0003" orientation="portrait" position="float"><label>Table 3</label><caption><p><citation_analysis attribute="neither">Adjusted ORs and 95% CIs for the Associations of IR with OSA (PS as the Reference), SWS (SWS &gt; 22.1% as the Reference) and Their Joint Effects (PS as Reference)</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Predictors</th><th rowspan="2" colspan="1">n</th><th colspan="3" rowspan="1">OR (95% CI)</th></tr><tr><th rowspan="1" colspan="1">Model 1</th><th rowspan="1" colspan="1">Model 2</th><th rowspan="1" colspan="1">Model 3</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">OSA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> PS</td><td rowspan="1" colspan="1">1257</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Reference</td></tr><tr><td rowspan="1" colspan="1"> OSA</td><td rowspan="1" colspan="1">5709</td><td rowspan="1" colspan="1">*2.009 (1.721–2.346)</td><td rowspan="1" colspan="1">*1.956(1.670–2.292)</td><td rowspan="1" colspan="1">*1.876 (1.592–2.211)</td></tr><tr><td rowspan="1" colspan="1">SWS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> &gt; 22.1%</td><td rowspan="1" colspan="1">1748</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Reference</td></tr><tr><td rowspan="1" colspan="1"> 13.8–22.1%</td><td rowspan="1" colspan="1">1742</td><td rowspan="1" colspan="1">1.012 (0.872–1.175)</td><td rowspan="1" colspan="1">1.048 (0.901–1.219)</td><td rowspan="1" colspan="1">1.071 (0.917–1.252)</td></tr><tr><td rowspan="1" colspan="1"> 7–13.7%</td><td rowspan="1" colspan="1">1739</td><td rowspan="1" colspan="1">1.023 (0.881–1.189)</td><td rowspan="1" colspan="1">1.043 (0.896–1.214)</td><td rowspan="1" colspan="1">0.996 (0.851–1.166)</td></tr><tr><td rowspan="1" colspan="1"> &lt; 6.9%</td><td rowspan="1" colspan="1">1737</td><td rowspan="1" colspan="1">*1.345 (1.156–1.566)</td><td rowspan="1" colspan="1">*1.371 (1.175–1.600)</td><td rowspan="1" colspan="1">1.093 (0.927–1.287)</td></tr><tr><td rowspan="1" colspan="1">p for linear trend</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">0.565</td></tr><tr><td rowspan="1" colspan="1">OSA-SWS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> PS</td><td rowspan="1" colspan="1">1257</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Reference</td></tr><tr><td rowspan="1" colspan="1"> &gt; 21.3%</td><td rowspan="1" colspan="1">1427</td><td rowspan="1" colspan="1">*1.927 (1.605–2.314)</td><td rowspan="1" colspan="1">*1.860 (1.543–2.241)</td><td rowspan="1" colspan="1">1.810 (1.493–2.193)</td></tr><tr><td rowspan="1" colspan="1"> 13.1–21.3%</td><td rowspan="1" colspan="1">1434</td><td rowspan="1" colspan="1">*1.858 (1.549–2.230)</td><td rowspan="1" colspan="1">*1.824 (1.514–2.197)</td><td rowspan="1" colspan="1">1.785 (1.474–2.160)</td></tr><tr><td rowspan="1" colspan="1"> 6.5–13%</td><td rowspan="1" colspan="1">1412</td><td rowspan="1" colspan="1">*1.817 (1.510–2.187)</td><td rowspan="1" colspan="1">*1.775 (1.470–2.143)</td><td rowspan="1" colspan="1">1.721 (1.417–2.090)</td></tr><tr><td rowspan="1" colspan="1"> &lt; 6.5%</td><td rowspan="1" colspan="1">1436</td><td rowspan="1" colspan="1">*2.662 (2.203–3.217)</td><td rowspan="1" colspan="1">*2.597 (2.140–3.150)</td><td rowspan="1" colspan="1">*2.461 (2.018–3.002)</td></tr><tr><td rowspan="1" colspan="1">p for linear trend</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn id="tfn0004"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="positive">: Model 1 was adjusted for age, BMI, and sex; Model 2 was adjusted for variables included in Model 1 and alcohol consumption, smoking, hypertension, diabetes mellitus and hyperlipidemia; Model 3 was adjusted for variables included in Model 2 and TST, SE, ESS in analysis of the joint effects of OSA and SWS on IR. Model 3 was adjusted for variables included in Model 2 and TST, SE, ESS, SWS% (in analysis of OSA and IR) or AHI (in analysis of SWS and IR). Logistic regression was used to further analyze the data.</citation_analysis></p><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="positive">: OR, odds ratio; CI, confidence interval; IR, insulin resistance; OSA, obstructive sleep apnea; PS, primary snorers; SWS, slow wave sleep; BMI, body mass index; TST, total sleep time; SE, sleep efficiency; ESS, Epworth Sleepiness Scale; AHI, apnea-hypopnea index. *p indicated a significant difference. PS group was the reference category for OSA and interaction of OSA and SWS. Group of subjects with SWS &gt; 22.1% was the reference category for SWS categories to find the association of IR and SWS.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      <p><citation_analysis attribute="neither">SWS was significantly associated with IR in OSA patients (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0004" ref-type="table">Table 4</xref></citation_analysis><citation_analysis attribute="positive">). A low percentage of SWS was associated with an increased risk of IR when OSA was present. After adjusting for potential confounders, OSA patients with SWS &lt; 6.5% were 34.8% (odds ratio [OR], 1.348 [95% CI, 1.133–1.603]) more likely to have IR than those with SWS &gt; 21.3% (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0004" ref-type="table">Table 4</xref></citation_analysis><citation_analysis attribute="positive">). No significant relationship between SWS and IR was found in the PS group. Furthermore, SWS was significantly associated with IR in OSA patients varying in severity (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0005" ref-type="table">Table 5</xref></citation_analysis><citation_analysis attribute="neither">). Using PS subjects as the reference, subjects with the lowest percentage of SWS showed the highest likelihood of IR, especially in moderate to severe OSA patients (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0005" ref-type="table">Table 5</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0004" orientation="portrait" position="float"><label>Table 4</label><caption><p><citation_analysis attribute="neither">Adjusted ORs and 95% CIs for the Association Between SWS and IR in OSA (SWS &gt; 21.3% as the Reference) and PS Groups (SWS &gt; 24.7% as the Reference)</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Predictors</th><th rowspan="2" colspan="1">n</th><th colspan="3" rowspan="1">OR (95% CI)</th></tr><tr><th rowspan="1" colspan="1">Model 1</th><th rowspan="1" colspan="1">Model 2</th><th rowspan="1" colspan="1">Model 3</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">OSA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> &gt; 21.3%</td><td rowspan="1" colspan="1">1427</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Reference</td></tr><tr><td rowspan="1" colspan="1"> 13.1–21.3%</td><td rowspan="1" colspan="1">1434</td><td rowspan="1" colspan="1">0.966 (0.822–1.137)</td><td rowspan="1" colspan="1">0.986 (0.836–1.163)</td><td rowspan="1" colspan="1">0.989 (0.837–1.169)</td></tr><tr><td rowspan="1" colspan="1"> 6.5–13%</td><td rowspan="1" colspan="1">1412</td><td rowspan="1" colspan="1">0.946 (0.803–1.114)</td><td rowspan="1" colspan="1">0.956 (0.810–1.128)</td><td rowspan="1" colspan="1">0.950 (0.802–1.125)</td></tr><tr><td rowspan="1" colspan="1"> &lt; 6.5%</td><td rowspan="1" colspan="1">1436</td><td rowspan="1" colspan="1">*1.389 (1.175–1.641)</td><td rowspan="1" colspan="1">*1.393 (1.176–1.651)</td><td rowspan="1" colspan="1">*1.348 (1.133–1.603)</td></tr><tr><td rowspan="1" colspan="1">p for linear trend</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">PS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> &gt; 24.7%</td><td rowspan="1" colspan="1">310</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Reference</td></tr><tr><td rowspan="1" colspan="1"> 17.1–24.7%</td><td rowspan="1" colspan="1">319</td><td rowspan="1" colspan="1">1.069 (0.728–1.57)</td><td rowspan="1" colspan="1">1.093 (0.737–1.621)</td><td rowspan="1" colspan="1">1.150 (0.764–1.730)</td></tr><tr><td rowspan="1" colspan="1"> 10.6–17%</td><td rowspan="1" colspan="1">312</td><td rowspan="1" colspan="1">1.066 (0.727–1.563)</td><td rowspan="1" colspan="1">1.171 (0.791–1.733)</td><td rowspan="1" colspan="1">1.167 (0.775–1.756)</td></tr><tr><td rowspan="1" colspan="1"> &lt; 10.6%</td><td rowspan="1" colspan="1">316</td><td rowspan="1" colspan="1">1 (0.68–1.47)</td><td rowspan="1" colspan="1">1.041 (0.699–1.549)</td><td rowspan="1" colspan="1">1.119 (0.740–1.692)</td></tr><tr><td rowspan="1" colspan="1">p for linear trend</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.999</td><td rowspan="1" colspan="1">0.876</td><td rowspan="1" colspan="1">0.882</td></tr></tbody></table><table-wrap-foot><fn id="tfn0005"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="positive">: Model 1 was adjusted for age, BMI, and sex; Model 2 was adjusted for variables included in Model 1 and alcohol consumption, smoking, hypertension, diabetes mellitus and hyperlipidemia; Model 3 was adjusted for variables included in Model 2 and TST, SE, and ESS. Logistic regression was used to further analyze the data. *p indicated a significant difference. Group of OSA subjects with SWS &gt; 21.3% was the reference category for SWS categories to find the association of IR and SWS in OSA. Group of PS with SWS &gt; 24.7% was the reference category for SWS categories to find the association of IR and SWS in primary snoring subjects.</citation_analysis></p><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: OR, odds ratio; CI, confidence interval; SWS, slow wave sleep; IR, insulin resistance; OSA, obstructive sleep apnea; PS, primary snorers; BMI, body mass index; TST, total sleep time; SE, sleep efficiency; ESS, Epworth Sleepiness Scale.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0005" orientation="portrait" position="float"><label>Table 5</label><caption><p><citation_analysis attribute="neither">Adjusted ORs and 95% CIs of IR Associated with SWS in Analyses Stratified by OSA Severity</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Predictors</th><th rowspan="2" colspan="1">n</th><th colspan="3" rowspan="1">OR (95% CI)</th></tr><tr><th rowspan="1" colspan="1">Model 1</th><th rowspan="1" colspan="1">Model 2</th><th rowspan="1" colspan="1">Model 3</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">PS</td><td rowspan="1" colspan="1">1257</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Reference</td></tr><tr><td rowspan="1" colspan="1">Mild OSA</td><td rowspan="1" colspan="1">1115</td><td colspan="3" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">&gt; 21.3%</td><td rowspan="1" colspan="1">332</td><td rowspan="1" colspan="1">*1.560 (1.187–2.050)</td><td rowspan="1" colspan="1">*1.496 (1.133–1.974)</td><td rowspan="1" colspan="1">*1.407 (1.045–1.894)</td></tr><tr><td rowspan="1" colspan="1">13.1–21.3%</td><td rowspan="1" colspan="1">341</td><td rowspan="1" colspan="1">1.198 (0.910–1.577)</td><td rowspan="1" colspan="1">1.209 (0.915–1.597)</td><td rowspan="1" colspan="1">1.222 (0.917–1.629)</td></tr><tr><td rowspan="1" colspan="1">6.5–13%</td><td rowspan="1" colspan="1">233</td><td rowspan="1" colspan="1">*1.419 (1.035–1.945)</td><td rowspan="1" colspan="1">*1.451 (1.054–1.997)</td><td rowspan="1" colspan="1">*1.431 (1.019–2.011)</td></tr><tr><td rowspan="1" colspan="1">&lt; 6.5%</td><td rowspan="1" colspan="1">209</td><td rowspan="1" colspan="1">*1.865 (1.273–2.733)</td><td rowspan="1" colspan="1">*1.793 (1.212–2.653)</td><td rowspan="1" colspan="1">*1.652 (1.097–2.487)</td></tr><tr><td rowspan="1" colspan="1">p for linear trend</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1">0.027</td></tr><tr><td rowspan="1" colspan="1">Moderate OSA</td><td rowspan="1" colspan="1">1133</td><td colspan="3" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">&gt; 21.3%</td><td rowspan="1" colspan="1">316</td><td rowspan="1" colspan="1">*1.898 (1.436–2.507)</td><td rowspan="1" colspan="1">*1.889 (1.424–2.507)</td><td rowspan="1" colspan="1">*1.895 (1.422–2.525)</td></tr><tr><td rowspan="1" colspan="1">13.1–21.3%</td><td rowspan="1" colspan="1">340</td><td rowspan="1" colspan="1">*1.530 (1.162–2.016)</td><td rowspan="1" colspan="1">*1.545 (1.169–2.043)</td><td rowspan="1" colspan="1">*1.539 (1.160–2.043)</td></tr><tr><td rowspan="1" colspan="1">6.5–13%</td><td rowspan="1" colspan="1">289</td><td rowspan="1" colspan="1">*1.788 (1.340–2.386)</td><td rowspan="1" colspan="1">*1.769 (1.321–2.370)</td><td rowspan="1" colspan="1">*1.753 (1.305–2.356)</td></tr><tr><td rowspan="1" colspan="1">&lt; 6.5%</td><td rowspan="1" colspan="1">188</td><td rowspan="1" colspan="1">*2.507 (1.747–3.598)</td><td rowspan="1" colspan="1">*2.450 (1.696–3.540)</td><td rowspan="1" colspan="1">*2.405 (1.658–3.489)</td></tr><tr><td rowspan="1" colspan="1">p for linear trend</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Severe OSA</td><td rowspan="1" colspan="1">3461</td><td colspan="3" rowspan="1"/></tr><tr><td rowspan="1" colspan="1">&gt; 21.3%</td><td rowspan="1" colspan="1">743</td><td rowspan="1" colspan="1">*2.231 (1.789–2.781)</td><td rowspan="1" colspan="1">*2.141 (1.710–2.681)</td><td rowspan="1" colspan="1">*2.044 (1.623–2.575)</td></tr><tr><td rowspan="1" colspan="1">13.1–21.3%</td><td rowspan="1" colspan="1">729</td><td rowspan="1" colspan="1">*2.615 (2.095–3.263)</td><td rowspan="1" colspan="1">*2.508 (2.000–3.146)</td><td rowspan="1" colspan="1">*2.405 (1.907–3.033)</td></tr><tr><td rowspan="1" colspan="1">6.5–13%</td><td rowspan="1" colspan="1">860</td><td rowspan="1" colspan="1">*2.035 (1.643–2.521)</td><td rowspan="1" colspan="1">*1.976 (1.588–2.458)</td><td rowspan="1" colspan="1">*1.875 (1.497–2.349)</td></tr><tr><td rowspan="1" colspan="1">&lt; 6.5%</td><td rowspan="1" colspan="1">1129</td><td rowspan="1" colspan="1">*2.935 (2.383–3.615)</td><td rowspan="1" colspan="1">*2.899 (2.343–3.588)</td><td rowspan="1" colspan="1">*2.699 (2.168–3.360)</td></tr><tr><td rowspan="1" colspan="1">p for linear trend</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn id="tfn0006"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="positive">: Model 1 was adjusted for age, BMI, and sex; Model 2 was adjusted for variables included in Model 1 and alcohol consumption, smoking, hypertension, diabetes mellitus and hyperlipidemia; Model 3 was adjusted for variables included in Model 2 and TST, SE, and ESS. Logistic regression was used to further analyze the data. *p indicated a significant difference. Primary snoring group was the reference category for all groups.</citation_analysis></p><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: OR, odds ratio; CI, confidence interval; IR, insulin resistance; SWS, slow wave sleep; OSA, obstructive sleep apnea; PS, primary snorers; BMI, body mass index; TST, total sleep time; SE, sleep efficiency; ESS, Epworth Sleepiness Scale.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      <p><citation_analysis attribute="neither">Besides, we performed a subgroup analysis by sex (male, female), age (&lt; 60 years, ≥ 60 years) and BMI (&lt; 28 kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither">, ≥ 28 kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither">), SWS was correlated with IR in thinner subjects especially with SWS &lt; 6.5% (OR, 1.583; 95% CI, 1.223–2.050) (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/get_supplementary_file.php?f= 311130.docx">Table S2</ext-link></underline></citation_analysis><citation_analysis attribute="neither">). We also performed multivariable linear regression to explore the interaction of AHI and SWS. AHI, SWS and AHI*SWS were significantly associated with HOMA-IR in the model (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/get_supplementary_file.php?f= 311130.docx">Table S3</ext-link></underline></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
    </sec>
    <sec id="s0004">
      <title>Discussion</title>
      <p><citation_analysis attribute="positive">We explored the association between SWS and the development of IR with a large sample of OSA and PS subjects. We found a significant interaction between SWS and OSA in patients with IR. OSA patients with SWS &lt; 6.5% had higher odds of IR than primary snorers. AHI has been reported to increase the risk of IR after adjusting for confounding factors,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="neither"> and intermittent hypoxia might lead to hyperglycemia, hyperinsulinemia, and IR.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0035" ref-type="bibr">35</xref></citation_analysis><citation_analysis attribute="positive"> Our study reaffirmed that patients with OSA are more likely to have IR than primary snorers. Greater odds of developing IR were evident only in OSA patients with a low percentage of SWS, indicating that OSA and SWS interacted and had a joint effect on IR. Further studies are needed on oxidative stress, excitability of the sympathetic nervous system, inflammation, and the dysfunction of hypothalamic-pituitary-adrenal (HPA) axis</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="neither"> to reveal the potential mechanisms between OSA and IR.</citation_analysis></p>
      <p><citation_analysis attribute="positive">Less SWS is becoming recognized as a marker for an increased risk for IR. In a previous study, as SWS increased, the HOMA-IR index significantly decreased, suggesting that it has a significant effect on improving IR.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="neither"> Benedict</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0038" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="neither"> and Hermida</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0039" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="negative"> theorized that the reduced risk for new-onset type 2 diabetes mellitus in patients with hypertension observed with bedtime ingestion of angiotensin-converting enzyme inhibitors was partially mediated by improvement in SWS.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Endocrine metabolism is regulated by sleep and the circadian rhythm. Insufficient sleep, and circadian rhythm or sleep structure disorders, lead to the imbalance of metabolic homeostasis, and further, cause hypertension, diabetes mellitus, and multiple organ injury. The mechanism is related to systemic inflammation and IR,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0040" ref-type="bibr">40</xref></citation_analysis><citation_analysis attribute="neither"> accompanied by low expression of circadian clock genes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0041" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0042" ref-type="bibr">42</xref></citation_analysis><citation_analysis attribute="neither"> The circadian clock input signal related to chronic sleep deprivation directly reduces the expression of CRY proteins, which in turn activates the cAMP/PKA inflammation signaling pathway and leads to the synthesis of a series of inflammatory factors, resulting in a chronic low inflammatory state of the body. Inflammatory factors directly inhibit the PI3K/AKT signaling pathway, leading to IR and higher blood levels of glucose.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="neither"> Zhu</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="negative"> analyzed the bivariate correlation between sleep structure and glucose and insulin levels. Subjects with higher TS and SE and SWS phases (%TST) had lower 2 h blood glucose, better islet β-cell function, and higher insulin sensitivity. For the thinner people, the metabolic status is less affected by obesity than the obese people, so the risk of IR caused by the reduction of SWS is greater. Meanwhile, higher N1 and N2 were related to poorer glucose tolerance and insulin sensitivity. The SWS stage still had the same effect on glucose and insulin metabolism indicators after adjusting for age, sex, BMI, puberty status and AHI. Therefore, overactivity of the sympathetic nervous system and SWS reduction might eventually lead to IR.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0045" ref-type="bibr">45</xref></citation_analysis><citation_analysis attribute="positive"> Our study corroborates these previous findings, showing a graded relationship between less SWS and increased odds of IR. SWS may provide a reliable indicator of the biological and medical significance of OSA, although the percentage of SWS is not generally recommended as a criterion of severity in OSA. Meanwhile, OSA severity may modulate the effects of SWS on the odds of IR as the results above showed. Our main finding is that less SWS is associated with higher odds for IR in OSA but not in PS. It was more likely to be a threshold effect such that the odds of IR were significantly higher in the OSA patients with the lowest SWS quartile. OSA was independently associated with IR. OSA and SWS also have an interaction effect on IR.</citation_analysis></p>
      <p><citation_analysis attribute="positive">An advantage of our study was the large sample size, which increases representativity. In addition, this is the first study to report that SWS moderates the association between OSA and IR. However, there were several limitations. First, hospital-based, full-night PSG did not truly reflect routine sleep. PSG in the sleep center is the gold standard for examining sleep stages and detecting respiratory-related events; therefore, first-night effects and variation among nights could not be ruled out. Second, this study was cross-sectional and observational. Prospective longitudinal research to confirm the relationship between sleep structure and glucose tolerance. Third, because menopause was related to changes in sleep quality and glucose metabolism,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0047" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="positive"> our findings may differ based on menopausal status.</citation_analysis></p>
    </sec>
    <sec id="s0005">
      <title>Conclusions</title>
      <p><citation_analysis attribute="negative">SWS and OSA interact to increase the odds of developing IR. Compared to PS subjects, OSA is independently associated with IR after adjusting for potential confounding factors. The odds of IR in OSA patients are significantly higher for those in the lowest SWS quartile. Further studies are needed to elucidate the pathophysiological mechanisms underlying this relationship and to test the hypothesis that SWS enhancement may ameliorate the risk for IR.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p><citation_analysis attribute="neither">All of the authors are grateful to the staff in our sleep center and all of the subjects.</citation_analysis></p>
    </ack>
    <sec id="s0006">
      <title>Abbreviations</title>
      <p><citation_analysis attribute="neither">SWS, slow-wave sleep; OSA, obstructive sleep apnea; IR, insulin resistance; PS, primary snoring; REM, rapid eye movement; NREM, non-rapid eye movement; AHI, apnea hypopnea index; HOMA-IR, homeostasis model assessment for insulin resistance; PSG, polysomnography; ESS, Epworth Sleepiness Scale, EDS, excessive daytime sleepiness; BMI, body mass index; CI, confidence interval; SE, sleep efficiency; OR, odds ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; LSpO2, lowest oxygen saturation; ODI, oxygen desaturation index; SaO2, oxygen saturation.</citation_analysis></p>
    </sec>
    <sec id="s0007">
      <title>Data Sharing Statement</title>
      <p><citation_analysis attribute="neither">The datasets used and analyzed in this study are available from Huajun Xu, the corresponding author, on reasonable request.</citation_analysis></p>
    </sec>
    <sec id="s0008">
      <title>Ethics Approval and Consent to Participate</title>
      <p><citation_analysis attribute="positive">This study was performed in accordance with the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of Shanghai Jiao Tong University Affiliated Sixth People’s Hospital (Approval No: 2019-KY-050[K]) and was registered at the Chinese Clinical Trial Registry (No. ChiCTR1900025714). We obtained informed consent from all subjects.</citation_analysis></p>
    </sec>
    <sec id="s0009">
      <title>Author Contributions</title>
      <p><citation_analysis attribute="positive">The corresponding authors are responsible for the authenticity of the data. All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.</citation_analysis></p>
    </sec>
    <sec id="s0010" sec-type="COI-statement">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">The authors declare that there is no conflict of interest in the study.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Senaratna</surname>
<given-names>CV</given-names></string-name>, <string-name><surname>Perret</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Lodge</surname>
<given-names>CJ</given-names></string-name>, et al. <article-title>Prevalence of obstructive sleep apnea in the general population: a systematic review</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2017</year>;<volume>34</volume>:<fpage>70</fpage>–<lpage>81</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2016.07.002</pub-id><pub-id pub-id-type="pmid">27568340</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Marcus</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Brooks</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Ward</surname>
<given-names>SD</given-names></string-name>, et al. <article-title>Diagnosis and management of childhood obstructive sleep apnea syndrome</article-title>. <source><italic toggle="yes">Pediatrics</italic></source>. <year>2012</year>;<volume>130</volume>(<issue>3</issue>):<fpage>e714</fpage>–<lpage>755</lpage>. doi:<pub-id pub-id-type="doi">10.1542/peds.2012-1672</pub-id><pub-id pub-id-type="pmid">22926176</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Huang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Association of the serum irisin level with obstructive sleep apnea: a body mass index- and physical activity-matched study</article-title>. <source><italic toggle="yes">Endocr J</italic></source>. <year>2020</year>;<volume>67</volume>(<issue>6</issue>):<fpage>607</fpage>–<lpage>612</lpage>. doi:<pub-id pub-id-type="doi">10.1507/endocrj.EJ19-0590</pub-id><pub-id pub-id-type="pmid">32188796</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bagai</surname>
<given-names>K</given-names></string-name>. <article-title>Obstructive sleep apnea, stroke, and cardiovascular diseases</article-title>. <source><italic toggle="yes">Neurologist</italic></source>. <year>2010</year>;<volume>16</volume>(<issue>6</issue>):<fpage>329</fpage>–<lpage>339</lpage>.<pub-id pub-id-type="pmid">21150380</pub-id></mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Parrino</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Vaudano</surname>
<given-names>AE</given-names></string-name>. <article-title>The resilient brain and the guardians of sleep: new perspectives on old assumptions</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2018</year>;<volume>39</volume>:<fpage>98</fpage>–<lpage>107</lpage>.<pub-id pub-id-type="pmid">29054694</pub-id></mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bathory</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Tomopoulos</surname>
<given-names>S</given-names></string-name>. <article-title>Sleep regulation, physiology and development, sleep duration and patterns, and sleep hygiene in infants, toddlers, and preschool-age children</article-title>. <source><italic toggle="yes">Curr Probl Pediatr Adolesc Health Care</italic></source>. <year>2017</year>;<volume>47</volume>(<issue>2</issue>):<fpage>29</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">28117135</pub-id></mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Berry</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Budhiraja</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gottlieb</surname>
<given-names>DJ</given-names></string-name>, et al. <article-title>Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events – deliberations of the sleep apnea definitions task force of the American Academy of Sleep Medicine</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2012</year>;<volume>8</volume>(<issue>5</issue>):<fpage>597</fpage>–<lpage>619</lpage>.<pub-id pub-id-type="pmid">23066376</pub-id></mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Blunden</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Galland</surname>
<given-names>B</given-names></string-name>. <article-title>The complexities of defining optimal sleep: empirical and theoretical considerations with a special emphasis on children</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2014</year>;<volume>18</volume>(<issue>5</issue>):<fpage>371</fpage>–<lpage>378</lpage>.<pub-id pub-id-type="pmid">24629828</pub-id></mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wigren</surname>
<given-names>HK</given-names></string-name>, <string-name><surname>Porkka-Heiskanen</surname>
<given-names>T</given-names></string-name>. <article-title>Novel concepts in sleep regulation</article-title>. <source><italic toggle="yes">Acta Physiol (Oxf)</italic></source>. <year>2018</year>;<volume>222</volume>(<issue>4</issue>):<fpage>e13017</fpage>.<pub-id pub-id-type="pmid">29253320</pub-id></mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Léger</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Debellemaniere</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Rabat</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bayon</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Benchenane</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Chennaoui</surname>
<given-names>M</given-names></string-name>. <article-title>Slow-wave sleep: from the cell to the clinic</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2018</year>;<volume>41</volume>:<fpage>113</fpage>–<lpage>132</lpage>.<pub-id pub-id-type="pmid">29490885</pub-id></mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Xiong</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>H</given-names></string-name>, et al. <article-title>The association between obstructive sleep apnea syndrome and metabolic syndrome: a confirmatory factor analysis</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2019</year>;<volume>23</volume>(<issue>3</issue>):<fpage>1011</fpage>–<lpage>1019</lpage>.<pub-id pub-id-type="pmid">30820851</pub-id></mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Whitaker</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Lutsey</surname>
<given-names>PL</given-names></string-name>, <string-name><surname>Ogilvie</surname>
<given-names>RP</given-names></string-name>, et al. <article-title>Associations between polysomnography and actigraphy-based sleep indices and glycemic control among those with and without type 2 diabetes: the multi-ethnic study of atherosclerosis</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2018</year>;<volume>41</volume>:<fpage>11</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Leng</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>McEvoy</surname>
<given-names>CT</given-names></string-name>, <string-name><surname>Allen</surname>
<given-names>IE</given-names></string-name>, <string-name><surname>Yaffe</surname>
<given-names>K</given-names></string-name>. <article-title>Association of sleep-disordered breathing with cognitive function and risk of cognitive impairment: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">JAMA Neurol</italic></source>. <year>2017</year>;<volume>74</volume>(<issue>10</issue>):<fpage>1237</fpage>–<lpage>1245</lpage>.<pub-id pub-id-type="pmid">28846764</pub-id></mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Tan</surname>
<given-names>Y</given-names></string-name>. <article-title>A systematic review and dose-response meta-analysis of sleep duration and the occurrence of cognitive disorders</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2018</year>;<volume>22</volume>(<issue>3</issue>):<fpage>805</fpage>–<lpage>814</lpage>.<pub-id pub-id-type="pmid">28589251</pub-id></mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Barger</surname>
<given-names>LK</given-names></string-name>, <string-name><surname>Rajaratnam</surname>
<given-names>SMW</given-names></string-name>, <string-name><surname>Cannon</surname>
<given-names>CP</given-names></string-name>, et al. <article-title>Short sleep duration, obstructive sleep apnea, shiftwork, and the risk of adverse cardiovascular events in patients after an acute coronary syndrome</article-title>. <source><italic toggle="yes">J Am Heart Assoc</italic></source>. <year>2017</year>;<volume>6</volume>:<fpage>10</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Diekelmann</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Born</surname>
<given-names>J</given-names></string-name>. <article-title>The memory function of sleep</article-title>. <source><italic toggle="yes">Nat Rev Neurosci</italic></source>. <year>2010</year>;<volume>11</volume>(<issue>2</issue>):<fpage>114</fpage>–<lpage>126</lpage>.<pub-id pub-id-type="pmid">20046194</pub-id></mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ju</surname>
<given-names>YS</given-names></string-name>, <string-name><surname>Ooms</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Sutphen</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels</article-title>. <source><italic toggle="yes">Brain</italic></source>. <year>2017</year>;<volume>140</volume>(<issue>8</issue>):<fpage>2104</fpage>–<lpage>2111</lpage>.<pub-id pub-id-type="pmid">28899014</pub-id></mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Raison</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Rye</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>Woolwine</surname>
<given-names>BJ</given-names></string-name>, et al. <article-title>Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol</article-title>. <source><italic toggle="yes">Biol Psychiatry</italic></source>. <year>2010</year>;<volume>68</volume>(<issue>10</issue>):<fpage>942</fpage>–<lpage>949</lpage>.<pub-id pub-id-type="pmid">20537611</pub-id></mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tasali</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Leproult</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ehrmann</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Van Cauter</surname>
<given-names>E</given-names></string-name>. <article-title>Slow-wave sleep and the risk of type 2 diabetes in humans</article-title>. <source><italic toggle="yes">Proc Natl Acad Sci USA</italic></source>. <year>2008</year>;<volume>105</volume>(<issue>3</issue>):<fpage>1044</fpage>–<lpage>1049</lpage>.<pub-id pub-id-type="pmid">18172212</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Somers</surname>
<given-names>VK</given-names></string-name>, <string-name><surname>Dyken</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Mark</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Abboud</surname>
<given-names>FM</given-names></string-name>. <article-title>Sympathetic-nerve activity during sleep in normal subjects</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>1993</year>;<volume>328</volume>(<issue>5</issue>):<fpage>303</fpage>–<lpage>307</lpage>.<pub-id pub-id-type="pmid">8419815</pub-id></mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Subramanian</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hesselbacher</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mattewal</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Surani</surname>
<given-names>S</given-names></string-name>. <article-title>Gender and age influence the effects of slow-wave sleep on respiration in patients with obstructive sleep apnea</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2013</year>;<volume>17</volume>(<issue>1</issue>):<fpage>51</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">22252284</pub-id></mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Artunc</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Schleicher</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Weigert</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Fritsche</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Stefan</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Häring</surname>
<given-names>HU</given-names></string-name>. <article-title>The impact of insulin resistance on the kidney and vasculature</article-title>. <source><italic toggle="yes">Nat Rev Nephrol</italic></source>. <year>2016</year>;<volume>12</volume>(<issue>12</issue>):<fpage>721</fpage>–<lpage>737</lpage>.<pub-id pub-id-type="pmid">27748389</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Punjabi</surname>
<given-names>NM</given-names></string-name>, <string-name><surname>Shahar</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Redline</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gottlieb</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Givelber</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Resnick</surname>
<given-names>HE</given-names></string-name>. <article-title>Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study</article-title>. <source><italic toggle="yes">Am J Epidemiol</italic></source>. <year>2004</year>;<volume>160</volume>(<issue>6</issue>):<fpage>521</fpage>–<lpage>530</lpage>.<pub-id pub-id-type="pmid">15353412</pub-id></mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shaw</surname>
<given-names>ND</given-names></string-name>, <string-name><surname>McHill</surname>
<given-names>AW</given-names></string-name>, <string-name><surname>Schiavon</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Effect of slow wave sleep disruption on metabolic parameters in adolescents</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2016</year>;<volume>39</volume>(<issue>8</issue>):<fpage>1591</fpage>–<lpage>1599</lpage>.<pub-id pub-id-type="pmid">27166229</pub-id></mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gonnissen</surname>
<given-names>HK</given-names></string-name>, <string-name><surname>Mazuy</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rutters</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Martens</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Adam</surname>
<given-names>TC</given-names></string-name>, <string-name><surname>Westerterp-Plantenga</surname>
<given-names>MS</given-names></string-name>. <article-title>Sleep architecture when sleeping at an unusual circadian time and associations with insulin sensitivity</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2013</year>;<volume>8</volume>(<issue>8</issue>):<fpage>e72877</fpage>.<pub-id pub-id-type="pmid">23951335</pub-id></mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Buxton</surname>
<given-names>OM</given-names></string-name>, <string-name><surname>Pavlova</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Reid</surname>
<given-names>EW</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Simonson</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Adler</surname>
<given-names>GK</given-names></string-name>. <article-title>Sleep restriction for 1 week reduces insulin sensitivity in healthy men</article-title>. <source><italic toggle="yes">Diabetes</italic></source>. <year>2010</year>;<volume>59</volume>(<issue>9</issue>):<fpage>2126</fpage>–<lpage>2133</lpage>.<pub-id pub-id-type="pmid">20585000</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chung</surname>
<given-names>KF</given-names></string-name>. <article-title>Use of the Epworth Sleepiness Scale in Chinese patients with obstructive sleep apnea and normal hospital employees</article-title>. <source><italic toggle="yes">J Psychosom Res</italic></source>. <year>2000</year>;<volume>49</volume>(<issue>5</issue>):<fpage>367</fpage>–<lpage>372</lpage>.<pub-id pub-id-type="pmid">11164062</pub-id></mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Johns</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hocking</surname>
<given-names>B</given-names></string-name>. <article-title>Daytime sleepiness and sleep habits of Australian workers</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>1997</year>;<volume>20</volume>(<issue>10</issue>):<fpage>844</fpage>–<lpage>849</lpage>.<pub-id pub-id-type="pmid">9415943</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Xu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Development and validation of a simple-to-use clinical nomogram for predicting obstructive sleep apnea</article-title>. <source><italic toggle="yes">BMC Pulm Med</italic></source>. <year>2019</year>;<volume>19</volume>(<issue>1</issue>):<fpage>18</fpage>.<pub-id pub-id-type="pmid">30658615</pub-id></mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bonora</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Targher</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Alberiche</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity</article-title>. <source><italic toggle="yes">Diabetes Care</italic></source>. <year>2000</year>;<volume>23</volume>(<issue>1</issue>):<fpage>57</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">10857969</pub-id></mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>McAuley</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Mann</surname>
<given-names>JI</given-names></string-name>, et al. <article-title>Diagnosing insulin resistance in the general population</article-title>. <source><italic toggle="yes">Diabetes Care</italic></source>. <year>2001</year>;<volume>24</volume>(<issue>3</issue>):<fpage>460</fpage>–<lpage>464</lpage>.<pub-id pub-id-type="pmid">11289468</pub-id></mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Catapano</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Graham</surname>
<given-names>I</given-names></string-name>, <string-name><surname>De Backer</surname>
<given-names>G</given-names></string-name>, et al. <article-title>2016 ESC/EAS Guidelines for the management of dyslipidaemias</article-title>. <source><italic toggle="yes">Eur Heart J</italic></source>. <year>2016</year>;<volume>37</volume>(<issue>39</issue>):<fpage>2999</fpage>–<lpage>3058</lpage>.<pub-id pub-id-type="pmid">27567407</pub-id></mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ho</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Crainiceanu</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Punjabi</surname>
<given-names>NM</given-names></string-name>, <string-name><surname>Redline</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gottlieb</surname>
<given-names>DJ</given-names></string-name>. <article-title>Calibration model for apnea-hypopnea indices: impact of alternative criteria for hypopneas</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2015</year>;<volume>38</volume>(<issue>12</issue>):<fpage>1887</fpage>–<lpage>1892</lpage>.<pub-id pub-id-type="pmid">26564122</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ip</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Lam</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Ng</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Lam</surname>
<given-names>WK</given-names></string-name>, <string-name><surname>Tsang</surname>
<given-names>KW</given-names></string-name>, <string-name><surname>Lam</surname>
<given-names>KS</given-names></string-name>. <article-title>Obstructive sleep apnea is independently associated with insulin resistance</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2002</year>;<volume>165</volume>(<issue>5</issue>):<fpage>670</fpage>–<lpage>676</lpage>.<pub-id pub-id-type="pmid">11874812</pub-id></mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zou</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Xia</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Independent relationships between cardinal features of obstructive sleep apnea and glycometabolism: a cross-sectional study</article-title>. <source><italic toggle="yes">Metabolism</italic></source>. <year>2018</year>;<volume>85</volume>:<fpage>340</fpage>–<lpage>347</lpage>.<pub-id pub-id-type="pmid">29382505</pub-id></mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gaines</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Vgontzas</surname>
<given-names>AN</given-names></string-name>, <string-name><surname>Fernandez-Mendoza</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bixler</surname>
<given-names>EO</given-names></string-name>. <article-title>Obstructive sleep apnea and the metabolic syndrome: the road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2018</year>;<volume>42</volume>:<fpage>211</fpage>–<lpage>219</lpage>.<pub-id pub-id-type="pmid">30279095</pub-id></mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Huang</surname>
<given-names>WY</given-names></string-name>, <string-name><surname>Zou</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>FE</given-names></string-name>, et al. <article-title>Jiao-tai-wan up-regulates hypothalamic and peripheral circadian clock gene cryptochrome and activates PI3K/AKT signaling in partially sleep-deprived rats</article-title>. <source><italic toggle="yes">Curr Med Sci</italic></source>. <year>2018</year>;<volume>38</volume>(<issue>4</issue>):<fpage>704</fpage>–<lpage>713</lpage>.<pub-id pub-id-type="pmid">30128882</pub-id></mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Benedict</surname>
<given-names>C</given-names></string-name>. <article-title>Antihypertensive medication prior to nocturnal sleep reduces the risk of new-onset type 2 diabetes in hypertensive patients: a role for slow-wave sleep?</article-title>
<source><italic toggle="yes">Diabetologia</italic></source>. <year>2016</year>;<volume>59</volume>(<issue>2</issue>):<fpage>390</fpage>–<lpage>391</lpage>.<pub-id pub-id-type="pmid">26471900</pub-id></mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hermida</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Ayala</surname>
<given-names>DE</given-names></string-name>, <string-name><surname>Mojón</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Fernández</surname>
<given-names>JR</given-names></string-name>. <article-title>Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial</article-title>. <source><italic toggle="yes">Diabetologia</italic></source>. <year>2016</year>;<volume>59</volume>(<issue>2</issue>):<fpage>255</fpage>–<lpage>265</lpage>.<pub-id pub-id-type="pmid">26399404</pub-id></mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Leproult</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Holmbäck</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Van Cauter</surname>
<given-names>E</given-names></string-name>. <article-title>Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss</article-title>. <source><italic toggle="yes">Diabetes</italic></source>. <year>2014</year>;<volume>63</volume>(<issue>6</issue>):<fpage>1860</fpage>–<lpage>1869</lpage>.<pub-id pub-id-type="pmid">24458353</pub-id></mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Brager</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Ehlen</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Castanon-Cervantes</surname>
<given-names>O</given-names></string-name>, et al. <article-title>Sleep loss and the inflammatory response in mice under chronic environmental circadian disruption</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2013</year>;<volume>8</volume>(<issue>5</issue>):<fpage>e63752</fpage>.<pub-id pub-id-type="pmid">23696854</pub-id></mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Qian</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Scheer</surname>
<given-names>F</given-names></string-name>. <article-title>Circadian system and glucose metabolism: implications for physiology and disease</article-title>. <source><italic toggle="yes">Trends Endocrinol Metab</italic></source>. <year>2016</year>;<volume>27</volume>(<issue>5</issue>):<fpage>282</fpage>–<lpage>293</lpage>.<pub-id pub-id-type="pmid">27079518</pub-id></mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Au</surname>
<given-names>CT</given-names></string-name>, et al. <article-title>Association between sleep architecture and glucose tolerance in children and adolescents</article-title>. <source><italic toggle="yes">J Diabetes</italic></source>. <year>2015</year>;<volume>7</volume>(<issue>1</issue>):<fpage>10</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">25695111</pub-id></mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Esler</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rumantir</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wiesner</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Kaye</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Hastings</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lambert</surname>
<given-names>G</given-names></string-name>. <article-title>Sympathetic nervous system and insulin resistance: from obesity to diabetes</article-title>. <source><italic toggle="yes">Am J Hypertens</italic></source>. <year>2001</year>;<volume>14</volume>(<issue>11 Pt 2</issue>):<fpage>304s</fpage>–<lpage>309s</lpage>.<pub-id pub-id-type="pmid">11721888</pub-id></mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Matthews</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Dahl</surname>
<given-names>RE</given-names></string-name>, <string-name><surname>Owens</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Hall</surname>
<given-names>M</given-names></string-name>. <article-title>Sleep duration and insulin resistance in healthy black and white adolescents</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2012</year>;<volume>35</volume>(<issue>10</issue>):<fpage>1353</fpage>–<lpage>1358</lpage>.<pub-id pub-id-type="pmid">23024433</pub-id></mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shaver</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Woods</surname>
<given-names>NF</given-names></string-name>. <article-title>Sleep and menopause: a narrative review</article-title>. <source><italic toggle="yes">Menopause</italic></source>. <year>2015</year>;<volume>22</volume>(<issue>8</issue>):<fpage>899</fpage>–<lpage>915</lpage>.<pub-id pub-id-type="pmid">26154276</pub-id></mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ley</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Tobias</surname>
<given-names>DK</given-names></string-name>, et al. <article-title>Duration of reproductive life span, age at menarche, and age at menopause are associated with risk of cardiovascular disease in women</article-title>. <source><italic toggle="yes">J Am Heart Assoc</italic></source>. <year>2017</year>;<volume>6</volume>:<fpage>11</fpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
